-
INO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Inovio Pharmaceuticals (INO)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 21.69 mm | 21.69 mm | 21.69 mm | 21.69 mm | 21.69 mm | |
Cash burn (monthly) | (no burn) | 2.59 mm | 9.12 mm | 10.15 mm | 7.01 mm | |
Cash used (since last report) | n/a | 7.23 mm | 25.51 mm | 28.40 mm | 19.62 mm | |
Cash remaining | n/a | 14.45 mm | -3.82 mm | -6.71 mm | 2.07 mm | |
Runway (months of cash) | n/a | 5.6 | -0.4 | -0.7 | 0.3 |
13F holders | Current |
---|---|
Total holders | 99 |
Opened positions | 39 |
Closed positions | 18 |
Increased positions | 19 |
Reduced positions | 17 |
13F shares | Current |
---|---|
Total value | 64.73 bn |
Total shares | 8.06 mm |
Total puts | 193.45 k |
Total calls | 305.64 k |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
Deep Track Capital | 2.07 mm | $16.70 bn |
BLK BlackRock | 1.71 mm | $13.79 bn |
Vanguard | 1.58 mm | $12.78 bn |
Geode Capital Management | 582.80 k | $4.71 bn |
STT State Street | 439.25 k | $3.55 bn |
Renaissance Technologies | 410.57 k | $3.32 bn |
MS Morgan Stanley | 103.71 k | $837.95 mm |
Susquehanna Fundamental Investments | 99.99 k | $807.93 mm |
BK The Bank of New York Mellon Corporation | 81.83 k | $661.23 mm |
Qube Research & Technologies | 79.28 k | $640.57 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Dec 24 | Michael John Sumner | RSU Common Stock | Grant | Acquire A | No | No | 0 | 4,292 | 0.00 | 4,292 |
18 Dec 24 | Michael John Sumner | Common Stock Option Common Stock | Grant | Acquire A | No | No | 1.78 | 5,708 | 10.16 k | 5,708 |
30 Jun 24 | Michael John Sumner | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,917 | 0.00 | 8,219 |
30 Jun 24 | Michael John Sumner | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,917 | 0.00 | 2,916 |
21 May 24 | David B. Weiner | RSU Common Stock | Grant | Acquire A | No | No | 0 | 2,167 | 0.00 | 2,167 |
21 May 24 | David B. Weiner | Common Stock Options Common Stock | Grant | Acquire A | No | No | 10.99 | 2,917 | 32.06 k | 2,917 |
21 May 24 | Miller Ann Calby | RSU Common Stock | Grant | Acquire A | No | No | 0 | 2,167 | 0.00 | 2,167 |
21 May 24 | Miller Ann Calby | Common Stock Options Common Stock | Grant | Acquire A | No | No | 10.99 | 2,917 | 32.06 k | 2,917 |
21 May 24 | Yarno Wendy L | RSU Common Stock | Grant | Acquire A | No | No | 0 | 2,167 | 0.00 | 2,167 |
21 May 24 | Yarno Wendy L | Common Stock Options Common Stock | Grant | Acquire A | No | No | 10.99 | 2,917 | 32.06 k | 2,917 |